Document is current
Any future updates will be listed below
-
Authors
Funaishi, Kunihiko
Yamaguchi, Kakuhiro
Tanahashi, Hiroki
Kurose, Koji
Sakamoto, Shinjiro
Horimasu, Yasushi
Masuda, Takeshi
Nakashima, Taku
Iwamoto, Hiroshi
Hamada, Hironobu
Oga, Toru
Oka, Mikio
Hattori, Noboru
-
Funding
Funding for this research was provided by:
Hiroshima University
- License Information
-
More Information
Article History
Received: 29 August 2024
Accepted: 9 January 2025
First Online: 24 January 2025
Declarations
:
: Noboru Hattori declares receiving research funding from Ono Pharmaceutical and Chugai Pharmaceutical. Noboru Hattori declare receiving personal fees from Ono Pharmaceutical, Chugai Pharmaceutical, and MSD. Taku Nakashima declares receiving research funding from MSD. Takeshi Masuda and Kakuhiro Yamaguchi declare receiving personal fees from Ono Pharmaceutical and Chugai Pharmaceutical. No other disclosures are reported. The Department of Immuno-Oncology (M. O.) was endowed to Kawasaki Medical School by Pole Star Co., Ltd., but they had no influence on the work reported in this article.
